Elutia Inc. (ELUT)
NASDAQ: ELUT · Real-Time Price · USD
0.8100
+0.0098 (1.22%)
At close: Sep 11, 2026, 4:00 PM EDT
0.805859
-0.0041 (-0.51%)
After-hours: Sep 11, 2026, 6:11 PM EDT
Elutia Revenue
Elutia had revenue of $2.43M in the quarter ending June 30, 2026, a decrease of -11.65%. This brings the company's revenue in the last twelve months to $12.14M, down -18.16% year-over-year. In the year 2025, Elutia had annual revenue of $12.29M, down -15.03%.
Revenue (ttm)
$12.14M
Revenue Growth
-18.16%
P/S Ratio
2.96
Revenue / Employee
$466,769
Employees
26
Market Cap
35.87M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 12.29M | -2.17M | -15.03% |
| Dec 31, 2024 | 14.47M | -10.28M | -41.54% |
| Dec 31, 2023 | 24.75M | 896.00K | 3.76% |
| Dec 31, 2022 | 23.85M | -23.54M | -49.68% |
| Dec 31, 2021 | 47.39M | 4.71M | 11.03% |
| Dec 31, 2020 | 42.68M | -219.00K | -0.51% |
| Dec 31, 2019 | 42.90M | 3.86M | 9.90% |
| Dec 31, 2018 | 39.04M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Accuray | 401.95M |
| Nortech Systems | 124.65M |
| Xtant Medical Holdings | 109.53M |
| TELA Bio | 79.91M |
| SANUWAVE Health | 44.02M |
| QT Imaging Holdings | 26.43M |
| Baird Medical Investment Holdings | 24.49M |
| Nano-X Imaging | 15.63M |
ELUT News
- 2 days ago - Elutia Transcript: H.C. Wainwright 28th Annual Global Investment Conference - Transcripts
- 3 days ago - Elutia to Present at the H.C. Wainwright 28th Annual Global Investment Conference on September 15th - GlobeNewsWire
- 11 days ago - Elutia to Participate in the Lake Street Capital Markets 10th Annual Big Ideas Growth Conference & the H.C. Wainwright 28th Annual Global Investment Conference - GlobeNewsWire
- 26 days ago - Cellution Biologics completes SimpliDerm acquisition from Elutia - TheFly
- 26 days ago - Cellution Biologics Completes Acquisition of SimpliDerm® from Elutia Inc. - GlobeNewsWire
- 26 days ago - Elutia Completes SimpliDerm® Sale on Schedule, Adds $8 Million in Cash to Fund NXT-41x Through Full Commercial Launch - GlobeNewsWire
- 4 weeks ago - Elutia Earnings Call Transcript: Q2 2026 - Transcripts
- 4 weeks ago - Elutia Earnings release: Q2 2026 - Filings